BBLG
Bone Biologics
BBLG
BBLG
4 hedge funds and large institutions have $89.1K invested in Bone Biologics in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.
Holders
4
Holders Change
+2
Holders Change %
+100%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AC
1
Armistice Capital
New York
|
$78.8K |
| 2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$9.05K |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$1.28K |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $78.8K | 37,000 | +37,000 | New |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $9.05K | 4,250 | +3,025 | +247% |
|
|
3
UBS Group
Zurich,
Switzerland
| $1.28K | 600 | +600 | New |
|
4
Wells Fargo
San Francisco,
California
| $9 | 4 | – | – |
|
|
CFGS
5
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|